Michael Jeltsch (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Michael Jeltsch" in English language version.

refsWebsite

Global rank English rank

10nih.gov

4^th place

7doi.org

2^nd place

3uspto.gov

1,459^th place

991^st place

2helsinki.fi

1,670^th place

2,355^th place

1researcherid.com

low place

1harvard.edu

18^th place

17^th place

1jeltsch.org

low place

doi.org

Jeltsch, M; Kaipainen, A; Joukov, V; Meng, X; Lakso, M; Rauvala, H; Swartz, M; Fukumura, D; Jain, RK; Alitalo, K (30 May 1997). "Hyperplasia of lymphatic vessels in VEGF-C transgenic mice". Science. 276 (5317): 1423–5. doi:10.1126/science.276.5317.1423. PMID 9162011.
Oh, SJ; Jeltsch, MM; Birkenhäger, R; McCarthy, JE; Weich, HA; Christ, B; Alitalo, K; Wilting, J (1 August 1997). "VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane". Developmental Biology. 188 (1): 96–109. doi:10.1006/dbio.1997.8639. PMID 9245515.
Achen, MG; Jeltsch, M; Kukk, E; Mäkinen, T; Vitali, A; Wilks, AF; Alitalo, K; Stacker, SA (20 January 1998). "Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)". Proceedings of the National Academy of Sciences of the United States of America. 95 (2): 548–53. Bibcode:1998PNAS...95..548A. doi:10.1073/pnas.95.2.548. PMC 18457. PMID 9435229.
Mandriota, SJ; Jussila, L; Jeltsch, M; Compagni, A; Baetens, D; Prevo, R; Banerji, S; Huarte, J; Montesano, R; Jackson, DG; Orci, L; Alitalo, K; Christofori, G; Pepper, MS (15 February 2001). "Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis". The EMBO Journal. 20 (4): 672–82. doi:10.1093/emboj/20.4.672. PMC 145430. PMID 11179212.
Gerhardt, H; Golding, M; Fruttiger, M; Ruhrberg, C; Lundkvist, A; Abramsson, A; Jeltsch, M; Mitchell, C; Alitalo, K; Shima, D; Betsholtz, C (23 June 2003). "VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia". The Journal of Cell Biology. 161 (6): 1163–77. doi:10.1083/jcb.200302047. PMC 2172999. PMID 12810700.
Jeltsch, M; Karpanen, T; Strandin, T; Aho, K; Lankinen, H; Alitalo, K (28 April 2006). "Vascular endothelial growth factor (VEGF)/VEGF-C mosaic molecules reveal specificity determinants and feature novel receptor binding patterns". The Journal of Biological Chemistry. 281 (17): 12187–95. doi:10.1074/jbc.m511593200. PMID 16505489.
Jeltsch, M; Jha, SK; Tvorogov, D; Anisimov, A; Läppänen, V-M; Holopainen, T; Kivelä, R; Ortega, S; Kärpänen, T; Alitalo, K (19 February 2014). "CCBE1 Enhances Lymphangiogenesis via A Disintegrin and Metalloprotease With Thrombospondin Motifs-3–Mediated Vascular Endothelial Growth Factor-C Activation". Circulation. 129 (19): 1962–71. doi:10.1161/circulationaha.113.002779. PMID 24552833.

harvard.edu

ui.adsabs.harvard.edu

Achen, MG; Jeltsch, M; Kukk, E; Mäkinen, T; Vitali, A; Wilks, AF; Alitalo, K; Stacker, SA (20 January 1998). "Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)". Proceedings of the National Academy of Sciences of the United States of America. 95 (2): 548–53. Bibcode:1998PNAS...95..548A. doi:10.1073/pnas.95.2.548. PMC 18457. PMID 9435229.

helsinki.fi

research.med.helsinki.fi

"Michael Jeltsch, University of Helsinki". research.med.helsinki.fi. 13 February 2017.

med.helsinki.fi

"The winner of the "Best Paper Award" of Circulation - Michael Jeltsch". med.helsinki.fi. 10 June 2016.

jeltsch.org

lab.jeltsch.org

"Affiliation". lab.jeltsch.org.

nih.gov

pubmed.ncbi.nlm.nih.gov

Jeltsch, M; Kaipainen, A; Joukov, V; Meng, X; Lakso, M; Rauvala, H; Swartz, M; Fukumura, D; Jain, RK; Alitalo, K (30 May 1997). "Hyperplasia of lymphatic vessels in VEGF-C transgenic mice". Science. 276 (5317): 1423–5. doi:10.1126/science.276.5317.1423. PMID 9162011.
Oh, SJ; Jeltsch, MM; Birkenhäger, R; McCarthy, JE; Weich, HA; Christ, B; Alitalo, K; Wilting, J (1 August 1997). "VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane". Developmental Biology. 188 (1): 96–109. doi:10.1006/dbio.1997.8639. PMID 9245515.
Achen, MG; Jeltsch, M; Kukk, E; Mäkinen, T; Vitali, A; Wilks, AF; Alitalo, K; Stacker, SA (20 January 1998). "Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)". Proceedings of the National Academy of Sciences of the United States of America. 95 (2): 548–53. Bibcode:1998PNAS...95..548A. doi:10.1073/pnas.95.2.548. PMC 18457. PMID 9435229.
Mandriota, SJ; Jussila, L; Jeltsch, M; Compagni, A; Baetens, D; Prevo, R; Banerji, S; Huarte, J; Montesano, R; Jackson, DG; Orci, L; Alitalo, K; Christofori, G; Pepper, MS (15 February 2001). "Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis". The EMBO Journal. 20 (4): 672–82. doi:10.1093/emboj/20.4.672. PMC 145430. PMID 11179212.
Gerhardt, H; Golding, M; Fruttiger, M; Ruhrberg, C; Lundkvist, A; Abramsson, A; Jeltsch, M; Mitchell, C; Alitalo, K; Shima, D; Betsholtz, C (23 June 2003). "VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia". The Journal of Cell Biology. 161 (6): 1163–77. doi:10.1083/jcb.200302047. PMC 2172999. PMID 12810700.
Jeltsch, M; Karpanen, T; Strandin, T; Aho, K; Lankinen, H; Alitalo, K (28 April 2006). "Vascular endothelial growth factor (VEGF)/VEGF-C mosaic molecules reveal specificity determinants and feature novel receptor binding patterns". The Journal of Biological Chemistry. 281 (17): 12187–95. doi:10.1074/jbc.m511593200. PMID 16505489.
Jeltsch, M; Jha, SK; Tvorogov, D; Anisimov, A; Läppänen, V-M; Holopainen, T; Kivelä, R; Ortega, S; Kärpänen, T; Alitalo, K (19 February 2014). "CCBE1 Enhances Lymphangiogenesis via A Disintegrin and Metalloprotease With Thrombospondin Motifs-3–Mediated Vascular Endothelial Growth Factor-C Activation". Circulation. 129 (19): 1962–71. doi:10.1161/circulationaha.113.002779. PMID 24552833.

ncbi.nlm.nih.gov

Achen, MG; Jeltsch, M; Kukk, E; Mäkinen, T; Vitali, A; Wilks, AF; Alitalo, K; Stacker, SA (20 January 1998). "Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)". Proceedings of the National Academy of Sciences of the United States of America. 95 (2): 548–53. Bibcode:1998PNAS...95..548A. doi:10.1073/pnas.95.2.548. PMC 18457. PMID 9435229.
Mandriota, SJ; Jussila, L; Jeltsch, M; Compagni, A; Baetens, D; Prevo, R; Banerji, S; Huarte, J; Montesano, R; Jackson, DG; Orci, L; Alitalo, K; Christofori, G; Pepper, MS (15 February 2001). "Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis". The EMBO Journal. 20 (4): 672–82. doi:10.1093/emboj/20.4.672. PMC 145430. PMID 11179212.
Gerhardt, H; Golding, M; Fruttiger, M; Ruhrberg, C; Lundkvist, A; Abramsson, A; Jeltsch, M; Mitchell, C; Alitalo, K; Shima, D; Betsholtz, C (23 June 2003). "VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia". The Journal of Cell Biology. 161 (6): 1163–77. doi:10.1083/jcb.200302047. PMC 2172999. PMID 12810700.